Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Minority Interest (2017 - 2021)

Innoviva's (INVA) quarterly Minority Interest came in at $111.2 million in Q4 2021, up 63.7% YoY from $67.9 million in Q4 2020, and up 24.94% on a QoQ basis from $89.0 million in Q3 2021.

Analysis

Innoviva (INVA) Minority Interest (2017 - 2021) Analysis & Trends

Innoviva (INVA) has 5 years of Minority Interest data on file, last reported at $111.2 million in Q4 2021.

  • Quarterly Minority Interest rose 63.7% year-over-year to $111.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $111.2 million (up 63.7% YoY) and the FY2021 annual result came in at $111.2 million, up 63.7% from the prior year.
  • Minority Interest improved to $111.2 million in Q4 2021, from $89.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $111.2 million in Q4 2021 to a low of $152000.0 in Q4 2017.
  • A 5-year average of $35.0 million and a median of $26.3 million in 2020 frame the typical range for Minority Interest.
  • Annual changes were most pronounced in 2018 — Minority Interest jumped 3498.03% — and 2021, when it surged 63.7%.
  • Tracing INVA's Minority Interest over 5 years: stood at $152000.0 in 2017, then jumped by 3498.03% to $5.5 million in 2018, then jumped by 423.33% to $28.6 million in 2019, then jumped by 137.33% to $67.9 million in 2020, then surged by 63.7% to $111.2 million in 2021.
  • The last three Minority Interest figures came in at $111.2 million (Q4 2021), $89.0 million (Q3 2021), and $64.0 million (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 111.19 Mn
Sep 30, 2021 88.99 Mn
Jun 30, 2021 63.97 Mn
Mar 31, 2021 62.22 Mn
Dec 31, 2020 67.93 Mn
Sep 30, 2020 49.32 Mn
Jun 30, 2020 35.91 Mn
Mar 31, 2020 26.33 Mn
Dec 31, 2019 28.62 Mn
Sep 30, 2019 16.71 Mn
Jun 30, 2019 20.02 Mn
Mar 31, 2019 11.70 Mn
Dec 31, 2018 5.47 Mn
Sep 30, 2018 3.08 Mn
Jun 30, 2018 1.99 Mn
Mar 31, 2018 811,000.00
Dec 31, 2017 152,000.00